Rep. Carolyn Maloney (D-NY) (Bill Clark/CQ Roll Call via AP Images)
March 14, 2022 01:12 PM EDT
Pharma
Law

House com­mit­tee calls on DOJ to in­ves­ti­gate com­pa­nies' opi­oid set­tle­ment tax ben­e­fits

Zachary Brennan

Senior Editor

Four com­pa­nies that al­leged­ly helped fu­el the opi­oid epi­dem­ic re­cent­ly agreed to pay about $26 bil­lion to set­tle thou­sands of re­lat­ed law­suits, but they al­so …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Vac­cine biotechs say they’ve been told to stop next-gen Covid work un­der a Biden-era project

Re­cent FDA staff cuts to de­lay drug hear­ing de­ci­sion by months, agency tells Van­da

Drug­mak­ers stock­pile in­ven­to­ry in the US, seek­ing to get ahead of Trump tar­iffs

Up­dat­ed: Roche’s $50B US in­vest­ment in­cludes pre­vi­ous build an­nounce­ments

Re­gen­eron to boost its US man­u­fac­tur­ing through a $3B Fu­ji­film deal

sponsored

AD­STI­LADRIN® (nad­o­fara­gene fi­rade­n­ovec-vncg) – A Grow­ing Body of Clin­i­cal Da­ta and Re­al-World Ev­i­dence

A service from the Financial Times